Candel shareholders elect three Class I directors, ratify KPMG as auditor

Candel Therapeutics, Inc.

Renee Gaeta, Gary J. Nabel, and Joseph C. Papa elected as Class I directors for three-year terms (for/withheld: 13.7M/2.3M, 11.6M/4.4M, 12.8M/3.2M).
Ratification of KPMG as independent auditor for FY2025 passed with 32.2M for, 199K against, 240K abstain.
Broker non-votes on director election totaled 16.7M shares; record date shares outstanding 49.3M.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.